BanchereauJ., SteinmanR.M.: Dendritic cells and the control of immunity.Nature, 392: 245–252, 1998.
2.
BoonT., Van der BruggenP.: Human tumor antigens recognized by T lymphocytes.J Exp Med, 183: 725–723, 1996.
3.
GabrilovichD.L., ChenH.L., GirgisK.R.: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.Nat Med, 10: 1096–1103, 1996.
4.
SallustoF., LanzavecchiaA.: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-a.J Exp Med, 179: 1109–1118, 1994.
5.
SteinmanR.M.: Dendritic cells and immune-based therapies.Exp Hematol, 24: 859–862, 1996.
6.
ReidC.D., StackpooleA., MeagerA., TikerpaeJ.: Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.J Immunol, 149: 2681–2688, 1992.
7.
RomaniN., GrunerS., BrangD.: Proliferating dendritic cell progenitors in human blood.J Exp Med, 180: 83–93, 1994.
8.
Santiago-SchwarzF., BelilosE., DiamondB., CarsonsS.E.: TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages.J Leukoc Biol, 52: 274–281, 1992.
9.
ZhouL., SchwartingR., SmithH.M., TedderT.F.: A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langherans cells and activated lymphocytes is a new member of the IG superfamily.J Immunol, 149: 735–742, 1992.
10.
MosialosG., BirkenbachM., AyehunieS.: Circulating human dendritic cells differentially express high levels of a 55-KD actin bundling protein.Am J Pathol, 148: 593–599, 1996.
11.
NestleF.O., AlijagicS., GillietM.: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.Nat Med, 4: 328–332, 1998.
12.
RibasA., ButterfieldL.H., GlaspyJ.A., EconomouJ.S.: Cancer immunotherapy using gene-modified dendritic cells.Curr Gene Ther, 2: 57–78, 2002.
13.
GilboaE., NairS.K., LyerlyH.K.: Immunotherapy of cancer with dendritic cell-based vaccines.Cancer Immunol Immunother, 46: 82–87, 1998.
14.
RosenbergS.A., YangJ.C., SchwartzentrubenD.J.: Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.Nat Med, 4: 321–327, 1998.
15.
HsuF.J., BenikeC., FagnoniF.: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.Nature Med, 2: 52–58, 1996.
